These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


302 related items for PubMed ID: 17962003

  • 1. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P, Nunthanid J, Luangtana-anan M, Weerapol Y, Puttipipatkhachorn S.
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [Abstract] [Full Text] [Related]

  • 2. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.
    Sriamornsak P, Nunthanid J, Luangtana-anan M, Puttipipatkhachorn S.
    Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664
    [Abstract] [Full Text] [Related]

  • 3. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J, Podczeck F, Newton JM.
    Int J Pharm; 2004 May 04; 275(1-2):41-60. PubMed ID: 15081137
    [Abstract] [Full Text] [Related]

  • 4. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    AAPS PharmSciTech; 2007 Aug 10; 8(3):E64. PubMed ID: 17915814
    [Abstract] [Full Text] [Related]

  • 5. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep 10; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 6. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov 10; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.
    Bose A, Harjoh N, Pal TK, Dan S, Wong TW.
    Expert Opin Drug Deliv; 2016 Nov 10; 13(1):143-54. PubMed ID: 26307229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
    Rabišková M, Bautzová T, Gajdziok J, Dvořáčková K, Lamprecht A, Pellequer Y, Spilková J.
    Int J Pharm; 2012 Jan 17; 422(1-2):151-9. PubMed ID: 22079717
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S, Kruenate J, Prahsarn C.
    Int J Pharm; 2006 Apr 07; 312(1-2):113-8. PubMed ID: 16490331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Swelling, erosion and release behavior of alginate-based matrix tablets.
    Sriamornsak P, Thirawong N, Korkerd K.
    Eur J Pharm Biopharm; 2007 Jun 07; 66(3):435-50. PubMed ID: 17267187
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.